Diabetes News and Research

Latest Diabetes News and Research

70% of adults with Type 1 diabetes never use blood glucose self-monitoring devices to download historical data

Almost 70 percent of adults with Type 1 diabetes never use their blood glucose self-monitoring devices or insulin pumps to download historical data about their blood sugar levels and insulin doses-information that likely would help them manage their disease better.

23 Jun 2014

Researchers identify two oncogenes that drive the development of medulloblastoma

A new collaborative study carried out by researchers at Sanford-Burnham Medical Research Institute, UC San Diego, the German Cancer Research Center, the University of Heidelberg (Germany), and 33 other research institutions has identified two oncogenes, called GFI1 and GFI1B, that drive the development of medulloblastoma, the most common malignant brain tumor in children.

23 Jun 2014

Study explores new ways to improve medications to treat type 2 diabetes

A better understanding of how the transcription factor Peroxisome Proliferator-Activated Receptor Gamma (PPARgamma) works is critical to find new ways to improve medications to treat type 2 diabetes.

23 Jun 2014

Researchers find possible biological reason why people with diabetes are prone to depression

Researchers have found a possible biological reason why people with diabetes are prone to depression.

23 Jun 2014

Private insurers clamp down on drug prices

More health plans are refusing to cover certain brand-name drugs unless drugmakers offer discounts for them, reports The New York Times.

23 Jun 2014

Women who develop gestational diabetes perform worse on cognitive function tests

Women who develop diabetes during pregnancy, called gestational diabetes, perform worse on cognitive function tests than do women with a normal pregnancy, according to a new study from Turkey.

23 Jun 2014

Empagliflozin lowers blood pressure in patients with Type 2 diabetes and hypertension

An investigational drug to treat Type 2 diabetes, empagliflozin, lowers blood pressure in patients with Type 2 diabetes and hypertension (high blood pressure), a new study finds.

23 Jun 2014

Treatment with diabetes drug liraglutide improves cardiovascular risk factors

Treatment with the diabetes drug liraglutide, in combination with diet and exercise, led to a significant reduction in weight and improved a number of cardiovascular risk factors, including high blood pressure and high cholesterol, according to a multicenter study.

23 Jun 2014

Long-term mild cold exposure can stimulate brown fat growth

Long-term mild cold exposure can stimulate brown fat growth and activity in humans and may benefit glucose and energy metabolism, a new study finds.

23 Jun 2014

Researchers shown how free radicals contribute to fatty liver disease

An international team of scientists led by Monash University researchers has shown how free radicals contribute to type 2 diabetes, obesity and fatty liver disease.

23 Jun 2014

African American women respond differently to anti-inflammatory effect of aspirin than white women

African American women respond differently to the anti-inflammatory effect of aspirin than do white American women, new research finds.

23 Jun 2014

BioLineRx announces in-licensing of BL-1110 compound for treatment of neuropathic pain

BioLineRx Ltd., a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today it has in-licensed BL-1110, a novel compound for the treatment of neuropathic pain.

23 Jun 2014

First Edition: June 23, 2014

Today's early morning highlights from the major news organizations, including news stories about healthcare.gov management changes.

23 Jun 2014

Study reveals that inflammasomes remain active even after cell death

Even after a cell dies, components of the immune system remain active and continue to fuel inflammatory reactions.

23 Jun 2014

Experts from 96 countries gather in Chicago to attend ICE/ENDO 2014

ICE/ENDO 2014, the joint meeting of the International Society of Endocrinology and the Endocrine Society, has tallied more registrants than any other annual meeting in the Endocrine Society's nearly 100-year history.

23 Jun 2014

Empagliflozin drug reduces blood pressure in patients with Type 2 diabetes, hypertension

An investigational drug to treat Type 2 diabetes, empagliflozin, lowers blood pressure in patients with Type 2 diabetes and hypertension (high blood pressure), a new study finds. The results were presented Sunday in a late-breaking abstract at the joint meeting of the International Society of Endocrinology and The Endocrine Society: ICE/ENDO 2014 in Chicago.

23 Jun 2014

Diabetes News and Research

Latest Diabetes News and Research

70% of adults with Type 1 diabetes never use blood glucose self-monitoring devices to download historical data

Researchers identify two oncogenes that drive the development of medulloblastoma

Study explores new ways to improve medications to treat type 2 diabetes

Researchers find possible biological reason why people with diabetes are prone to depression

Private insurers clamp down on drug prices

Women who develop gestational diabetes perform worse on cognitive function tests

Empagliflozin lowers blood pressure in patients with Type 2 diabetes and hypertension

Treatment with diabetes drug liraglutide improves cardiovascular risk factors

Long-term mild cold exposure can stimulate brown fat growth

Researchers shown how free radicals contribute to fatty liver disease

African American women respond differently to anti-inflammatory effect of aspirin than white women

BioLineRx announces in-licensing of BL-1110 compound for treatment of neuropathic pain

First Edition: June 23, 2014

Study reveals that inflammasomes remain active even after cell death

Experts from 96 countries gather in Chicago to attend ICE/ENDO 2014

Empagliflozin drug reduces blood pressure in patients with Type 2 diabetes, hypertension

Research roundup: Improving colon cancer screening; disparities in heart care; Medicaid expansion's effect on cities

Cubist Pharmaceuticals' SIVEXTRO receives FDA approval for treatment of ABSSSI

Greenlander study identifies single mutation with large diabetes risk

Continuation of metformin after cirrhosis diagnosis improves survival rates in diabetes patients

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Diabetes News and Research

Latest Diabetes News and Research

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Newsletters you may be interested in